Summarized by Masters of Longevity from Longevity Technology.
Digbi Health’s expansion into menopause care promises a data-driven health platform feature tour, showing how gut, genetics and hormones get integrated.
Key Takeaways
- The platform now integrates hormone replacement therapy with GLP-1, microbiome, genetics, CGM, and blood biomarker data for unified care.
- Digbi reports a corrected 48-point average drop in IBS symptom scores at 12 weeks among nearly 16,000 members.
- Claims of per-member savings and reduced total healthcare spend are supported by a peer-reviewed employer claims analysis reporting $3,012 lower annual spending.
